EPMT

In order to comply with Financial Services Authority Regulation No. 31/POJK.04/2015 dated December 16, 2015 concerning Disclosure of Material Information or Facts by Issuers or Public Companies, the following is a presentation of information for the public submitted by the Company.

Reduction of the authorized capital, issued capital, and paid-up capital of the Company's subsidiary, PT Mitra Ananda Megadistrindo
21 Jul 2026
Disclosure of information in relation to the transaction for the purchase and sale of tangible fixed assets between PT Forsta Kalmedic Global and PT Hale International.
24 Dec 2025
Information on the 2025 Public Expose Plan
27 Nov 2025
Changes to the Composition of Enseval's Audit Committee
04 Nov 2025
Changes in Share Ownership by the Company’s Controlling Shareholder.
26 Sep 2025
Increase of issued and paid-up capital in PT Livzon Pharma Indonesia (subsidiary owned through PT Global Chemindo Megatrading).
26 Sep 2025